Acid Reducer 150
NDC Package 57896-770-65

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Acid Reducer 150 is a . Marketed by Geri-care Pharmaceutical Corp, this product is identified by NDC 57896-770 and is authorized under FDA application ANDA200172.

Identification & Billing

NDC Package Code
57896-770-65
Package Description
65 TABLET, FILM COATED in 1 BOTTLE
Product Code
11-Digit Billing Format
57896077065

Clinical Specifications

Proprietary Name
Acid Reducer 150
Dosage Form
-

Regulatory & Marketing

Labeler Name
Geri-care Pharmaceutical Corp
FDA Application #
ANDA200172
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-01-2014
End Marketing Date
04-01-2020
Listing Expiration
04-01-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (57896-770). Click a package code to view its specific billing and regulatory data.

50 TABLET, FILM COATED in 1 BOTTLE
24 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 57896-770-65 identifies a specific commercial package of 65 tablet, film coated in 1 bottle of Acid Reducer 150, labeled by Geri-care Pharmaceutical Corp. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Geri-care Pharmaceutical Corp on November 01, 2014. The current certification is valid through April 01, 2020.

How is this Geri-care Pharmaceutical Corp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 57896077065. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
57896-770-65
11-Digit CMS (5-4-2)
57896-0770-65

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.